Position in TMO
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,510,963
+$1,066,525 QoQ
Shares Held
3,074
+300.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Gibbs Wealth Management holds $3,954,246 across 6 Diagnostics & Research names. TMO ranks #1 (38.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
This page
|
3,074 | $1,510,963 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
1,500 | $842,835 | |
| 3 | MEDP |
Medpace Holdings, Inc.
|
1,221 | $586,311 | |
| 4 | GH |
Guardant Health, Inc.
|
5,935 | $548,215 | |
| 5 | ILMN |
Illumina, Inc.
|
3,780 | $465,922 | |
| 6 | ADPT |
Adaptive Biotechnologies Corp
|
6,898 | $0 |
All Filings in TMO
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,510,963 | 3,074 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $444,438 | 767 | Shares | Other | 2026-01-23 | |
| 2025-09-30 | $377,830 | 779 | Shares | Other | 2025-10-30 | |
| 2025-06-30 | $2,771,319 | 6,835 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,030,384 | 6,090 | Shares | Other | 2025-11-04 | |
| 2024-12-31 | $2,676,583 | 5,145 | Shares | Other | 2025-11-04 | |
| 2024-09-30 | $2,649,953 | 4,284 | Shares | Other | 2025-11-04 | |
| 2024-06-30 | $1,560,013 | 2,821 | Shares | Other | 2025-11-04 | |
| 2024-03-31 | $1,057,220 | 1,819 | Shares | Other | 2025-11-04 | |
| No filing history on record for this holder in this stock. | ||||||